Company intelligence / Profile preview

Aksigen Hospital Care

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Aksigen Hospital Care commercializes enzyme-based combinations for edema, pain, and post-surgical inflammation, and is recognized for being the first in India to commercialize such products; some assets were acquired by Sun Pharma after clinical studies with DCGI approval for post-operative healing and inflammation reduction.

Therapeutic areas: CardiovascularImmunologyEndocrinologyRheumatologyNeurologyInfectious DiseasesOther
Modalities: Small moleculeEnzyme-based therapyBiologicHerbal
Industry: Biotech

Partnerships

Sun Pharma (asset acquisition, 2023)

Beyond the preview

Go deeper on Aksigen Hospital Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aksigen Hospital Care.

Explore the full profile